Free Daily Podcast Summary
Business Of Biotech: Daily Summaries Delivered
by Ben Comer
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries.
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- 2 days ago54 min
Using Genetics To Discover New Treatments With Regeneron Genetics Center's Aris Baras, M.D.
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Aris Baras, M.D., SVP, Head of Regeneron Genetics Center (RGC) and Co-Head of Regeneron Genetic Medicines, talks about using large-scale human genetics to find better drug targets based on "superhuman" variants. Aris explains how multi-omics, linked health records, and AI are helping developers move faster in the clinic and reduce the odds of failure, while also pushing biotech toward ea...
- 1 weeks ago56 min
Late-Stage Development And Commercial Planning With CervoMed's Matt Winton, Ph.D.
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Matt Winton, Ph.D., Chief Commercial and Business Officer at CervoMed, talks about preparing for the late-stage development of neflamapimod in dementia with Lewy bodies (DLB) and commercial planning for an anticipated launch. Winton talks about CMC and manufacturing scale-up, partnership, communicating with regulators and the benefits of global regulatory alignment on protocols for the P...
- 2 weeks ago48 min
BoB@BIO: Biotech In The Balance With Ovid Therapeutics' Dr. Jeremy Levin
We love to hear from our listeners. Send us a message. On the Business of Biotech this week, industry veteran Dr. Jeremy Levin, Founder, Chairman, and former CEO at Ovid Therapeutics, sits down alongside the 2026 BIO Convention to talk about why public distrust and politicized institutions are putting the scientific enterprise at risk. We dig into what biotech leaders owe patients and the public, how innovation and capital can migrate out of the U.S., and what it takes to build biotech compa...
- 3 weeks ago39 min
BoB@BIO: Biotech Investing And Deals With Sofinnova's Maha Radhakrishnan, M.D.
We love to hear from our listeners. Send us a message. This week's episode of the Business of Biotech was recorded at the BIO Convention in San Diego, where guest Maha Radhakrishnan, M.D., Executive Partner, Private Equity, at Sofinnova, spoke about her move from big pharma and biotech to private equity investing, and what makes a late-stage asset deal work. Maha also talks about how China-originated programs are changing development timelines, and where the next wave of CNS and metabolic in...
- Jun 29, 202648 min
Targeting Tau in Alzheimer's Disease With Voyager Therapeutics' Al Sandrock, M.D., Ph.D.
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Al Sandrock, M.D., Ph.D., President and CEO at Voyager Therapeutics, talks about why tau is becoming a central target in Alzheimer’s drug development and how gene therapy delivery across the blood-brain barrier could change what treatment looks like at scale. Sandrock shares his current thinking on the amyloid vs. beta debate (it's likely both) in Alzheimer's disease treatment, the role ...
- Jun 22, 202655 min
Keeping An Early-Stage Cell Therapy Biotech In The Black With IN8bio's William Ho
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, William Ho, CEO of IN8bio, explains why gamma delta T cells may have an edge against cancer, including solid tumors like glioblastoma. He also offers up a candid and step-by-step look at what it takes to finance an early clinical-stage cell therapy company through a punishing IPO market and a long cash crunch. Access this and hundreds of episodes of the Business of Biotech videocas...
- Jun 15, 202655 min
Drug Launch Success In A Changing Commercial Landscape With ACMA's William Soliman, Ph.D.
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, William Soliman, Founder and CEO of the Accreditation Council for Medical Affairs (ACMA), and Founder and CIO of White Manna Capital Partners, talks about why biotech drug launches so often miss expectations, and how to build an integrated commercialization plan that holds up with physicians, patients, and payers. William also describes the evolution in medical affairs, why standards and...
- Jun 8, 20261h 24m
The Editors' Roundtable: A Midyear Look At The 2026 Life Sciences Industry
We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Tyler Menichiello, chief editor at Bioprocess Online, host of the Better Biopharma podcast, and my Life Science Connect (LSC) colleague, convenes the broader LSC editorial team once again for a midyear discussion on what's happening now in the life sciences industry, and what's to come in the second half of the year. Topics include AI manufacturing regulations and navigating supply chain...
Get Business Of Biotech summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
Founder's Story
Real founders share raw stories of building, scaling, and leading companies, revealing the grit and purpose behind entrepreneurial success.
BiggerPockets Business Podcast
Real entrepreneurs share practical advice on starting, growing, and selling businesses, covering hiring, marketing, and raising capital.
Business Movers
True stories of visionary business leaders and the bold risks, successes, and failures that shaped iconic companies and changed the world.
Butternomics the Business of Culture
Explores how culture shapes business through interviews with entrepreneurs and tastemakers redefining brand strategy.
Right About Now - Legendary Business Advice
Real talk from business founders and entrepreneurs about building companies, lessons learned, and what actually works in real-world ventures.
DTC POD: How The Best Brands Are Built
Explores how direct-to-consumer brands are built, from startup to growth, through interviews with founders, marketers, and industry experts.
TBPN
A daily live tech talk show featuring interviews with major figures in Silicon Valley and the tech industry.
TechSurge: Deep Tech Podcast
Explores emerging technologies, startup challenges, and investment trends through conversations with founders, investors, and tech leaders.
The Digital Executive
A daily tech podcast exploring emerging technologies through interviews with Silicon Valley CEOs, influencers, and celebrities.
The Restless Ones
Executives at the intersection of technology and business discuss innovation, leadership, and driving change in fast-evolving industries.
The Entrepreneur DNA
Entrepreneurs share lessons on building businesses and personal growth through real experiences and mistakes.
Corporate Gossip
Two siblings dissect corporate scandals and boardroom drama with a mix of financial insight and gossip.
About Business Of Biotech
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, regulatory, and commercial challenges you’ll face as you navigate your company from an idea to success in the clinic and beyond. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries.
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Business Of Biotech in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Business Of Biotech daily summary?
It's a free AI-powered email that summarizes new episodes of Business Of Biotech as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Business Of Biotech podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Business Of Biotech product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by Ben Comer.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts. Upgrade to Pro for 15, or Premium for 50. Browse our full catalog at /podcasts.
How often does Business Of Biotech release new episodes?
Business Of Biotech publishes weekly. Our AI generates a summary within hours of each new episode.
What topics does Business Of Biotech cover?
Business Of Biotech covers topics including Science, Business, Management, Life Sciences. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Business Of Biotech summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.